BioNTech SE (BNTX) Gains from Investment Securities (2018 - 2022)

BioNTech SE has reported Gains from Investment Securities for 8 years, with the latest figure at -$931234.8 in Q4 2025.

• Quarterly Gains from Investment Securities fell 771.46% year-over-year to -$931234.8 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$2.9 million (down 2605.1% YoY) and the FY2025 annual result came in at -$2.8 million, down 781.07% from the prior year.
• Gains from Investment Securities grew to -$931234.8 in Q4 2025 per BNTX's latest filing, from -$1.5 million in the prior quarter.
• Over five years, Gains from Investment Securities peaked at $211.5 million in Q2 2021 and troughed at -$1.5 million in Q3 2025.
• A 5-year average of $12.1 million and a median of $155273.7 in 2023 frame the typical range for Gains from Investment Securities.
• The sharpest annual moves came in 2021 and 2025: Gains from Investment Securities jumped 29630710.57% in 2021, then sank 771.46% in 2025.
• Over 5 years, Gains from Investment Securities stood at $4.8 million in 2021, then plunged by 95.75% to $204049.5 in 2022, then grew by 5.46% to $215188.0 in 2023, then slumped by 149.66% to -$106859.5 in 2024, then plunged by 771.46% to -$931234.8 in 2025.
• According to Business Quant data, Gains from Investment Securities over the past three periods registered -$931234.8, -$1.5 million, and -$339587.9 for Q4 2025, Q3 2025, and Q2 2025 respectively.